In Q2 2025, Tang Capital Management held 148 positions worth $1.7B. They initiated 8 new positions and exited 63. Their largest holding was GLPGF ($111.7M).
Frequently asked questions
What stocks did Tang Capital Management own in Q2 2025?
Tang Capital Management held 148 biotech stocks in their 13F portfolio in Q2 2025. Their top positions include GLPGF, TARS, AUPH, IMCR, KNSA. The full holdings table is available on BiotechEdge with position sizes, quarter-over-quarter changes, and AI analysis.
How much was Tang Capital Management's portfolio worth in Q2 2025?
Tang Capital Management's tracked biotech portfolio was worth $1.7B across 148 positions, with total assets under management of approximately $2B. Portfolio values are based on 13F filings with the SEC.
What did Tang Capital Management buy in Q2 2025?
Tang Capital Management initiated 8 new positions in Q2 2025, including URGN, TVTX, SRPT, SMMT, VRTX and 3 more. They also increased 31 existing positions.
What did Tang Capital Management sell in Q2 2025?
Tang Capital Management fully exited 63 positions in Q2 2025, including EQ, CBAY, RNAC, SPRY, TLPH and 58 more. They also trimmed 34 existing positions.
Is Tang Capital Management a biotech fund?
Event-driven biotech specialist known for concentrated bets around clinical catalysts, M&A situations, and activist campaigns. Deep industry relationships and willingness to engage publicly make the fund a closely watched market signal.
Want AI analysis, insider signals, and catalyst overlays for Tang Capital Management?
View latest Tang Capital Managementportfolio →